» Articles » PMID: 35432263

Integrated Trinity Test With RPA-CRISPR/Cas12a-Fluorescence for Real-Time Detection of Respiratory Syncytial Virus A or B

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2022 Apr 18
PMID 35432263
Authors
Affiliations
Soon will be listed here.
Abstract

Respiratory syncytial virus (RSV) is a common virus that causes respiratory infection, especially severe respiratory infection in infants and young children, the elderly people over 65 years old, and people with weak immunity. Currently, RSV infection has no effective vaccine and antiviral treatment. The number of deaths due to RSV infection increases every year. Moreover, RSV A infection occurs in a large number and has severe clinical symptoms and complications than RSV B infection. Therefore, the development of a simple, rapid, and inexpensive detection method with high amplification efficiency, high sensitivity, and specificity is very important for the diagnosis of RSV A or RSV B infection, which can help in the early clinical medication and prevent the progress of the disease. Therefore, we developed an integrated trinity test with an RPA-CRISPR/Cas12a-fluorescence (termed IT-RAISE) assay system to detect RSV A or RSV B. The characteristic of the IT-RAISE system is that after target recognition, the reporter single-stranded DNA (ssDNA) is cleaved by Cas12a that is activated by different crRNAs to detect the generated fluorescent signal. This method is simple and helps in adding all reagents rapidly. It is a high-sensitive method that can detect 1.38 × 10 copies/μl of the target sequences, and it can distinguish RSV A or RSV B infection within 37 min. In addition, clinical specimens were detected for IT-RAISE system. It was found that the sensitivity and specificity of RSV A were 73.08 and 90%, respectively, and those of RSV B were 42.86 and 93.33%, respectively. The cost of ONE specimen for IT-RAISE system was approximately $ 2.6 (excluding rapid RNA extraction and reverse transcription costs). IT-RAISE system has good clinical application prospects for detecting RSV A or RSV B infection; it is a simple, rapid, and inexpensive method with high amplification efficiency, high sensitivity, and high specificity. The IT-RAISE system might also detect other viral or bacterial infections.

Citing Articles

Rapid and Ultrasensitive Detection of via the RPA-CRISPR/Cas12a Platform.

Wang X, Chen X, Xu T, Jin X, Jiang J, Guan F Molecules. 2024; 29(20).

PMID: 39459159 PMC: 11510235. DOI: 10.3390/molecules29204789.


A Method for Detecting Five Carbapenemases in Bacteria Based on CRISPR-Cas12a Multiple RPA Rapid Detection Technology.

Xu H, Lin C, Tang H, Li R, Xia Z, Zhu Y Infect Drug Resist. 2024; 17:1599-1614.

PMID: 38699075 PMC: 11063466. DOI: 10.2147/IDR.S429707.


Recombinase polymerase amplification combined with lateral flow dipstick assay for rapid visual detection of and in sea foods.

Wang X, Xu T, Ding S, Xu Y, Jin X, Guan F Heliyon. 2024; 10(7):e28943.

PMID: 38623257 PMC: 11016599. DOI: 10.1016/j.heliyon.2024.e28943.


A multiplex recombinase polymerase amplification assay combined with CRISPR/Cas12a for the detection of respiratory syncytial virus and respiratory adenovirus.

Hongdan G, Yao D, Qiang C, Meng H, Xiaorong L, Zhihao X J Int Med Res. 2024; 52(1):3000605231223083.

PMID: 38230675 PMC: 10798089. DOI: 10.1177/03000605231223083.


Comparative analysis of clinical features of lower respiratory tract infection with respiratory syncytial virus and influenza virus in adults: a retrospective study.

Tian J, Liu C, Wang X, Zhang L, Zhong G, Huang G BMC Pulm Med. 2023; 23(1):350.

PMID: 37715219 PMC: 10504734. DOI: 10.1186/s12890-023-02648-5.


References
1.
Banerjee D, Kanwar N, Hassan F, Essmyer C, Selvarangan R . Comparison of Six Sample-to-Answer Influenza A/B and Respiratory Syncytial Virus Nucleic Acid Amplification Assays Using Respiratory Specimens from Children. J Clin Microbiol. 2018; 56(11). PMC: 6204686. DOI: 10.1128/JCM.00930-18. View

2.
Nam H, Ison M . Respiratory syncytial virus infection in adults. BMJ. 2019; 366:l5021. DOI: 10.1136/bmj.l5021. View

3.
Zou X, Chang K, Wang Y, Li M, Zhang W, Wang C . Comparison of the Cepheid Xpert Xpress Flu/RSV assay and commercial real-time PCR for the detection of influenza A and influenza B in a prospective cohort from China. Int J Infect Dis. 2019; 80:92-97. DOI: 10.1016/j.ijid.2018.12.014. View

4.
Kirolos A, Christides A, Xian S, Reeves R, Nair H, Campbell H . A landscape review of the published research output relating to respiratory syncytial virus (RSV) in North & Central America and Europe between 2011-2015. J Glob Health. 2019; 9(1):010425. PMC: 6513410. DOI: 10.7189/jogh.09.010425. View

5.
Pierangeli A, Scagnolari C, Antonelli G . Respiratory syncytial virus. Minerva Pediatr. 2018; 70(6):553-565. DOI: 10.23736/S0026-4946.18.05312-4. View